Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Scatolini

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Endocrine|August 4, 2020
Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutationsRoberta Poli, Maria Scatolini, Enrico Grosso, et al.
Endocrinology|December 7, 2021
Ribociclib Cytotoxicity Alone or Combined With Progesterone and/or Mitotane in in Vitro Adrenocortical Carcinoma CellsAndrea Abate, Elisa Rossini, Mariangela Tamburello, et al.
Genes, Chromosomes & Cancer|January 24, 2018
Truncating mutations of TP53AIP1 gene predispose to cutaneous melanomaMeriem Benfodda, Steven Gazal, Vincent Descamps, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2024
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinomaMaria Scatolini, Salvatore Grisanti, Pasquale Tomaiuolo, et al.
Pathologica|April 9, 2026
Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancerUmberto Malapelle, Simonetta Buglioni, Isabella Castellano, et al.
Breast Cancer Research and Treatment|April 30, 2010
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancerMaurizia Mello-Grand, Vijay Singh, Chiara Ghimenti, et al.
Cancer Research|April 16, 2020
Targeting p63 Upregulation Abrogates Resistance to MAPK Inhibitors in MelanomaAnkit Patel, Lucia Fraile Garcia, Viviana Mannella, et al.
Endocrine-Related Cancer|May 11, 2026
Updating ACC preclinical models: characterization of two new patient-derived cell linesAndrea Abate, Mariangela Tamburello, Claudia Bonera, et al.
Frontiers in Endocrinology|October 20, 2025
Germline targeted next-generation sequencing in patients with adrenal incidentalomasErika Messina, Alessia Inglesi, Soraya Puglisi, et al.
Pigment Cell & Melanoma Research|September 27, 2014
Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2Patrizia Borsotti, Carmen Ghilardi, Paola Ostano, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Endocrine|August 4, 2020
Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutationsRoberta Poli, Maria Scatolini, Enrico Grosso, et al.
Endocrinology|December 7, 2021
Ribociclib Cytotoxicity Alone or Combined With Progesterone and/or Mitotane in in Vitro Adrenocortical Carcinoma CellsAndrea Abate, Elisa Rossini, Mariangela Tamburello, et al.
Genes, Chromosomes & Cancer|January 24, 2018
Truncating mutations of TP53AIP1 gene predispose to cutaneous melanomaMeriem Benfodda, Steven Gazal, Vincent Descamps, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2024
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinomaMaria Scatolini, Salvatore Grisanti, Pasquale Tomaiuolo, et al.
Pathologica|April 9, 2026
Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancerUmberto Malapelle, Simonetta Buglioni, Isabella Castellano, et al.
Breast Cancer Research and Treatment|April 30, 2010
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancerMaurizia Mello-Grand, Vijay Singh, Chiara Ghimenti, et al.
Cancer Research|April 16, 2020
Targeting p63 Upregulation Abrogates Resistance to MAPK Inhibitors in MelanomaAnkit Patel, Lucia Fraile Garcia, Viviana Mannella, et al.
Endocrine-Related Cancer|May 11, 2026
Updating ACC preclinical models: characterization of two new patient-derived cell linesAndrea Abate, Mariangela Tamburello, Claudia Bonera, et al.
Frontiers in Endocrinology|October 20, 2025
Germline targeted next-generation sequencing in patients with adrenal incidentalomasErika Messina, Alessia Inglesi, Soraya Puglisi, et al.
Pigment Cell & Melanoma Research|September 27, 2014
Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2Patrizia Borsotti, Carmen Ghilardi, Paola Ostano, et al.
Pageof 3